title: [Regression of severe periarticular calcifications during treatment with bisphosphonate in a dialysis patient].
abstract: Treatment with etidronate, 400 mg daily, induced total regression of severe, disabling periarticular calcifications during a treatment period of 42 months in a patient with chronic kidney disease on dialysis treatment. All symptoms disappeared. No adverse effects were recorded during the treatment. Thus, treatment with etidronate can induce regression of the periarticular calcifications which comprise a complication to chronic renal failure.
authors.affiliation: Regionshospitalet Holstebro, Medicinsk Afdeling, Denmark. damir@dadlnet.dk
authors.forename: Damir
authors.initials: D
authors.lastname: Obad
authors.forename: Niels A
authors.initials: NA
authors.lastname: Larsen
authors.forename: Erling B
authors.initials: EB
authors.lastname: Pedersen
mesh_terms: D050071:Bone Density Conservation Agents / Q000008:administration & dosage / Q000627:therapeutic use*; D002114:Calcinosis / Q000000981:diagnostic imaging / Q000188:drug therapy* / Q000209:etiology; D012968:Etidronic Acid / Q000008:administration & dosage / Q000627:therapeutic use*; D006801:Humans; D007676:Kidney Failure, Chronic / Q000097:blood / Q000150:complications* / Q000628:therapy; D008297:Male; D008875:Middle Aged; D011859:Radiography; D006435:Renal Dialysis / Q000009:adverse effects; D016896:Treatment Outcome
chemical_list: D050071:Bone Density Conservation Agents; D012968:Etidronic Acid